432 related articles for article (PubMed ID: 6468821)
1. [Clinical experience with propafenone in paroxysmal supraventricular reciprocating tachycardias].
Furlanello F; Vergara G; Dal Forno P; Disertori M; Inama G
G Ital Cardiol; 1984 May; 14(5):379-80. PubMed ID: 6468821
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and cure of the Wolff-Parkinson-White syndrome or paroxysmal supraventricular tachycardias during a single electrophysiologic test.
Calkins H; Sousa J; el-Atassi R; Rosenheck S; de Buitleir M; Kou WH; Kadish AH; Langberg JJ; Morady F
N Engl J Med; 1991 Jun; 324(23):1612-8. PubMed ID: 2030717
[TBL] [Abstract][Full Text] [Related]
3. [Wolff-Parkinson-White syndrome with paroxysmal supraventricular tachycardias of the fetus and the newborn--case report].
Gembruch U; Venn HJ; Redel DA; Hansmann M
Klin Padiatr; 1982; 194(5):320-3. PubMed ID: 7144049
[TBL] [Abstract][Full Text] [Related]
4. [Wolff-Parkinson-White syndrome with orthodromic supraventricular tachycardia associated with a "hyper-conductor" atrio-ventricular node. A therapeutic challenge].
Hernández González D; Iturralde Torres P; Romero L; Colín L; Villarreal A; González Hermosillo JA
Arch Inst Cardiol Mex; 1990; 60(2):175-81. PubMed ID: 2378538
[TBL] [Abstract][Full Text] [Related]
5. [The efficacy of propafenon in the case of supraventricular atrioventricular tachycardia].
Chachua T; Abuladze G; Nebieridze M
Georgian Med News; 2010 Jun; (183):18-21. PubMed ID: 20622270
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of programmed stimulation in predicting efficacy of propafenone in long-term antiarrhythmic therapy for paroxysmal supraventricular tachycardia.
Manz M; Steinbeck G; Lüderitz B
Am J Cardiol; 1985 Oct; 56(10):593-7. PubMed ID: 4050693
[TBL] [Abstract][Full Text] [Related]
7. [Electrophysiologic study of propafenon in Wolff-Parkinson-White syndrome].
Clémenty J; Sourdille N; Pedeboscq G; Bricaud H
Ann Cardiol Angeiol (Paris); 1982; 31(5):351-5. PubMed ID: 7158983
[No Abstract] [Full Text] [Related]
8. [Electrophysiologic effects and clinical efficacy of propafenone in pediatric patients with paroxysmal supraventricular reentrant tachycardia].
Musto B; D'Onofrio A; Musto A; Cavallaro C; Marsico F
G Ital Cardiol; 1986 Apr; 16(4):336-43. PubMed ID: 3743937
[TBL] [Abstract][Full Text] [Related]
9. [Sotalol in supraventricular tachycardia. Electrophysiologic measurements in Wolff-Parkinson-White syndrome and AV node re-entry tachycardia].
Manz M; Kuhl AJ; Lüderitz B
Z Kardiol; 1985 Sep; 74(9):500-5. PubMed ID: 4060827
[TBL] [Abstract][Full Text] [Related]
10. [Electrophysiologic effects of diprafenone in supraventricular and ventricular tachycardia].
Manz M; Beermann J; Gerckens U; Lüderitz B
Z Kardiol; 1986 Dec; 75(12):757-63. PubMed ID: 3825226
[TBL] [Abstract][Full Text] [Related]
11. [Comparative study on the efficacy of disopyramide and propafenone in the prevention of the recurrence of ventricular tachycardia].
Palmieri M; Capucci A; Lombardi G; Naccarella F; Bomba E; Bracchetti D
G Ital Cardiol; 1984 May; 14(5):357-9. PubMed ID: 6468817
[TBL] [Abstract][Full Text] [Related]
12. [Supraventricular paroxysmal reentry tachycardia. Empirical and guided therapy].
Piccolo E; Bonso A; Raviele A; Delise P
Cardiologia; 1991 Aug; 36(8 Suppl):87-97. PubMed ID: 1817777
[TBL] [Abstract][Full Text] [Related]
13. [Indications and risks of anti-arrhythmia treatment with propafenone (author's transl)].
Beck OA; Hochrein H
Dtsch Med Wochenschr; 1978 Aug; 103(32):1261-5. PubMed ID: 78793
[TBL] [Abstract][Full Text] [Related]
14. [Atrial fibrillation induced by massage of the carotid sinus in patients with orthodromic reciprocal supraventricular tachycardia and Wolff-Parkinson-White syndrome].
Paoloni P; Cardinali L; Pezzuoli F; Capone P
Minerva Cardioangiol; 1995; 43(1-2):55-9. PubMed ID: 7792019
[TBL] [Abstract][Full Text] [Related]
15. [Verapamil in the study and treatment of supraventricular tachycardias, with special reference to pre-excitation].
Krikler DM
Minerva Med; 1975 May; 66(39):1914-22. PubMed ID: 236526
[TBL] [Abstract][Full Text] [Related]
16. [Oral propafenone in refractory arrhythmia. Apropos of 68 patients].
Haissaguerre M; Wicker F; Goldrach S; Vrancea F; Regaudie JJ; Le Metayer P; Warin JF; Blanchot P
Ann Cardiol Angeiol (Paris); 1986 Mar; 35(3):173-9. PubMed ID: 3707020
[TBL] [Abstract][Full Text] [Related]
17. Double-blind study of intravenous propafenone for paroxysmal supraventricular reentrant tachycardia.
Hammill SC; McLaran CJ; Wood DL; Osborn MJ; Gersh BJ; Holmes DR
J Am Coll Cardiol; 1987 Jun; 9(6):1364-8. PubMed ID: 3584724
[TBL] [Abstract][Full Text] [Related]
18. Effect of propafenone in the Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up.
Breithardt G; Borggrefe M; Wiebringhaus E; Seipel L
Am J Cardiol; 1984 Nov; 54(9):29D-39D. PubMed ID: 6496367
[TBL] [Abstract][Full Text] [Related]
19. [Effect of oral propafenon on accessory pathways of atrioventricular conduction].
Lacroix H; Frank R; Tonet JL; Fontaine G; Wajman A; Squeir S; Grosgogeat Y
Arch Mal Coeur Vaiss; 1985 Apr; 78(4):622-7. PubMed ID: 2860884
[TBL] [Abstract][Full Text] [Related]
20. [Circulatory arrest after combined intravenous drugs for the treatment of orthodromic circular tachycardia of Wolff-Parkinson-White syndrome].
Gómez-Barrado JJ; García-Rubira JC; Turégano Albarrán S; Pavón García M; Hidalgo Urbano R; Montes Ramírez JM; Cruz Fernández JM
Rev Esp Cardiol; 1997 Sep; 50(9):662-6. PubMed ID: 9380937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
